{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:59:58Z","timestamp":1783990798530,"version":"3.55.0"},"reference-count":63,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T00:00:00Z","timestamp":1056067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Tumour necrosis factor\u2010related apoptosis\u2010inducing ligand (TRAIL) is a potent inducer of apoptosis in sensitive cells and may be suitable for novel anti\u2010cancer therapies aimed at inducing apoptosis via the activation of TRAIL receptors on malignant cells. Here we have characterized the TRAIL sensitivity of a panel of Burkitt's lymphoma (BL) cell lines. Overall, 5\/12 BL cell lines and 1\/2 lymphoblastoid cell lines were sensitive to TRAIL\u2010induced apoptosis, although only one BL cell line approached the sensitivity of Jurkat cells, a widely used model for TRAIL\u2010induced apoptosis. Whereas, 4\/5 of the Epstein\u2013Barr virus (EBV)\u2010negative cell lines were TRAIL sensitive, only 1\/7 EBV\u2010positive BL cell lines were TRAIL sensitive. However, isogenic BL cell lines with different EBV status were not differently sensitive to TRAIL, indicating that EBV is not a major determinant of TRAIL sensitivity. All cell lines expressed the death receptor (DR)5 TRAIL receptor, whereas expression of DR4 was more variable. Differences in the expression of downstream signalling molecules [Fas\u2010associated death domain protein (FADD), caspase 8] and inhibitors [decoy receptor 1 (DcR1), cellular FLICE\u2010like inhibitory protein (c\u2010FLIP)] did not correlate with TRAIL sensitivity. Therefore, a subset of BL cell lines are sensitive to TRAIL\u2010induced apoptosis, however, the molecular mechanism that determines responsiveness remains to be identified.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04424.x","type":"journal-article","created":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T13:49:16Z","timestamp":1056116956000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Regulation of tumour necrosis factor\u2010related apoptosis\u2010inducing ligand (TRAIL)\u2010induced apoptosis in Burkitt's lymphoma cell lines"],"prefix":"10.1111","volume":"122","author":[{"given":"Amalia","family":"Mouzakiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Packham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,6,20]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb00182.x"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1305"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(99)80034-9"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6926"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/35008667"},{"key":"e_1_2_15_7_1","first-page":"793","article-title":"Selectivity of TRAIL\u2010mediated apoptosis of cancer cells and synergy with drugs: the trail to non\u2010toxic cancer therapeutics","volume":"15","author":"Bonavida B.","year":"1999","journal-title":"International Journal of Oncology"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201704"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690805"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80400-8"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6194"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402169"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80399-4"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1165"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.23.14363"},{"key":"e_1_2_15_16_1","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V79.12.3300.bloodjournal79123300","article-title":"Expression of the APO\u20101 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype","volume":"79","author":"Falk M.H.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_15_17_1","first-page":"1688","article-title":"Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer","volume":"7","author":"Fisher M.J.","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-574"},{"key":"e_1_2_15_19_1","first-page":"3823","article-title":"The CD95 (APO\u20101\/Fas) system mediates drug\u2010induced apoptosis in neuroblastoma cells","volume":"57","author":"Fulda S.","year":"1997","journal-title":"Cancer Research"},{"key":"e_1_2_15_20_1","first-page":"696","article-title":"Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas\u2010induced apoptosis","volume":"59","author":"Gutierrez M.I.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.5.2400-2410.2001"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/40657"},{"key":"e_1_2_15_23_1","first-page":"335","article-title":"Molecular determinants of response to TRAIL in killing of normal and cancer cells","volume":"6","author":"Kim K.","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80212-5"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000284200"},{"key":"e_1_2_15_26_1","first-page":"1645","article-title":"Anti\u2010cancer agents sensitize tumor cells to tumor necrosis factor\u2010related apoptosis\u2010inducing ligand\u2010mediated caspase\u20108 activation and apoptosis","volume":"61","author":"Lacour S.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/86397"},{"key":"e_1_2_15_28_1","first-page":"5683","article-title":"Alterations of the DR5\/TRAIL receptor 2 gene in non\u2010small cell lung cancers","volume":"59","author":"Lee S.H.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204103"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402401"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.41.25417"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205853"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00422-2"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2991.2991_2991_2997"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/88684"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200101000-00076"},{"key":"e_1_2_15_37_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.160.1.3","article-title":"Lymphocyte inhibitor of TRAIL (TNF\u2010related apoptosis\u2010inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL","volume":"160","author":"Mongkolsapaya J.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M000482200"},{"key":"e_1_2_15_39_1","first-page":"847","article-title":"Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor\u2010related apoptosis\u2010inducing ligand in vitro and in vivo","volume":"60","author":"Nagane M.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011336726649"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.815"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5309.111"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)00135-5"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.22.12687"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)00409-8"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1693"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910370307"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02568.x"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2540439.x"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00297-1"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.818"},{"key":"e_1_2_15_52_1","first-page":"4942","article-title":"Mutations of tumor necrosis factor\u2010related apoptosis\u2010inducing ligand receptor 1 (TRAIL\u2010R1) and receptor 2 (TRAIL\u2010R2) genes in metastatic breast cancers","volume":"61","author":"Shin M.S.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402036"},{"key":"e_1_2_15_54_1","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/JVI.73.6.4678-4688.1999","article-title":"Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein\u2013Barr virus","volume":"73","author":"Spender L.C.","year":"1999","journal-title":"Journal of Virology"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80211-3"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M910438199"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00345-8"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204558"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020039225764"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.17.5386"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/5517"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90057-8"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1641"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.8.3961"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04424.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04424.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04424.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:06:22Z","timestamp":1697414782000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04424.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,20]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04424.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04424.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,20]]},"assertion":[{"value":"2003-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}